How many insider declarations has Bjork Elisabeth filed?

Bjork Elisabeth has filed 3 public insider declarations with SEC (Form 4).

What is Bjork Elisabeth's role?

Bjork Elisabeth's reported role is not specified by the regulator across the filings.

Which companies does Bjork Elisabeth report trades for?

Bjork Elisabeth reports trades for 2 companies, including Pharvaris N.V..

What is Bjork Elisabeth's declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 252k€.

← Executives ★ Sign in to follow

BE

Bjork Elisabeth

OFFICER

·SEC (Form 4)

Pharvaris N.V.Rocket Pharmaceuticals, INC.

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

€252,178

▼ Sales (1 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

1

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Discover the complete record of transactions filed by Bjork Elisabeth. Director active across 2 companies, notably Pharvaris N.V.. In total, 3 disclosures have been logged. Split: 0 buy · 1 sell. Total volume traded: €252k. Activity tracked since 18 June 2025. The latest transaction was filed on 20 May 2026 (Cession). Regulator: SEC (Form 4). The full history is free.

Companies and markets linked to Bjork Elisabeth

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Pharvaris N.V. (US)Rocket Pharmaceuticals, INC. (US)

Declarations3 total

◇

Bjork Elisabeth

DirectorExecutives20 May 2026Pharvaris N.V.

$80,50019SEC ↗

10,000 shares@ US$8.050.0033% mcap21.5% of flowCommon StockSEC:0001193125-26-236432:0

▼

Bjork Elisabeth

DirectorExecutives20 May 2026Pharvaris N.V.

$293,16639SEC ↗

10,000 shares@ US$29.31660.012% mcap78.5% of flowCommon StockSEC:0001193125-26-236432:1

◆

Bjork Elisabeth

DirectorExecutives18 Jun 2025Rocket Pharmaceuticals, INC.

0SEC ↗

30,000 shares0Common StockSEC:0001140361-25-026405:0

3 of 3 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

BE

Bjork Elisabeth

OFFICER

·SEC (Form 4)

Pharvaris N.V.Rocket Pharmaceuticals, INC.

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

€252,178

▼ Sales (1 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

1

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Discover the complete record of transactions filed by Bjork Elisabeth. Director active across 2 companies, notably Pharvaris N.V.. In total, 3 disclosures have been logged. Split: 0 buy · 1 sell. Total volume traded: €252k. Activity tracked since 18 June 2025. The latest transaction was filed on 20 May 2026 (Cession). Regulator: SEC (Form 4). The full history is free.